These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 17609226
21. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou-Grigoriadou V, Siasos G, Evangelopoulou E, Mathioudakis GA. Respirology; 2013 Jan; 18(1):147-53. PubMed ID: 22985270 [Abstract] [Full Text] [Related]
22. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Akazawa M, Biddle AK, Stearns SC. Clin Ther; 2008 Jan; 30 Spec No():1003-16. PubMed ID: 18640475 [Abstract] [Full Text] [Related]
23. Clinical Inquiry. Do inhaled steroids reduce bone mineral density and increase fracture risk? Wheelock C, Glass J, St Anna L. J Fam Pract; 2012 Aug; 61(8):493-508. PubMed ID: 22871660 [Abstract] [Full Text] [Related]
24. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL, Baker EL, Coleman CI. Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [Abstract] [Full Text] [Related]
25. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD. Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659 [Abstract] [Full Text] [Related]
30. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S, Crepaldi G, Nuti R, EOLO study group. Calcif Tissue Int; 2010 Aug; 87(2):137-43. PubMed ID: 20567964 [Abstract] [Full Text] [Related]
31. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Ernst P, Baltzan M, Deschênes J, Suissa S. Eur Respir J; 2006 Jun; 27(6):1168-74. PubMed ID: 16481387 [Abstract] [Full Text] [Related]
34. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM, White CM, Coleman CI. Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [Abstract] [Full Text] [Related]
35. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!]. Rochat T. Rev Med Suisse; 2008 Jan 16; 4(140):155-7. PubMed ID: 18309880 [Abstract] [Full Text] [Related]
36. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP. Curr Med Res Opin; 2012 Dec 16; 28(12):1959-67. PubMed ID: 23098081 [Abstract] [Full Text] [Related]
37. Oral health in patients on inhaled corticosteroid treatment. Komerik N, Akkaya A, Yildiz M, Buyukkaplan US, Kuru L. Oral Dis; 2005 Sep 16; 11(5):303-8. PubMed ID: 16120117 [Abstract] [Full Text] [Related]